Study Design of Motion: a 24-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Safinamide in Early Parkinson's Disease - Ongoing Clinical Trial
AuthID
P-003-3AT
P-003-3AT
© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service